Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$694,870
-$71,665 QoQ
Shares Held
5,500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,230
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mathes Company, Inc. holds $5,421,408 across 7 Drug Manufacturers - General names. GILD ranks #4 (12.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
48,623 | $1,170,841 | |
| 2 | AMGN |
Amgen Inc
|
3,095 | $1,120,761 | |
| 3 | LLY |
ELI LILLY & Co
|
772 | $925,960 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
5,500 | $694,870 | |
| 5 | JNJ |
Johnson & Johnson
|
2,641 | $670,734 | |
| 6 | MRK |
Merck & Co., Inc.
|
4,565 | $586,602 | |
| 7 | ABBV |
AbbVie Inc.
|
1,000 | $251,640 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $694,870 | 5,500 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $766,535 | 5,500 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $675,070 | 5,500 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $610,500 | 5,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $609,785 | 5,500 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $728,325 | 6,500 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $600,405 | 6,500 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $544,960 | 6,500 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $445,965 | 6,500 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $512,750 | 7,000 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $567,070 | 7,000 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $524,580 | 7,000 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $539,490 | 7,000 | Shares | Sole | 2023-07-25 | |
| 2022-12-31 | $684,653 | 7,975 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $491,977 | 7,975 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $492,934 | 7,975 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $474,113 | 7,975 | Shares | Sole | 2022-06-15 | |
| 2021-12-31 | $579,064 | 7,975 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $644,366 | 9,225 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $635,233 | 9,225 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $662,457 | 10,250 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $495,210 | 8,500 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $537,115 | 8,500 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $653,990 | 8,500 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $766,290 | 10,250 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||